The company has announced positive results for its “bionic eye” used in the treatment of dry AMD. Its shares gained more than 8% on January 8 on the the Paris Stock Exchange by middle of the day.
The company has announced positive results for its “bionic eye” used in the treatment of dry AMD. Its shares gained more than 8% on January 8 on the the Paris Stock Exchange by middle of the day.